BIOMAT Database Logo BIOMAT Database Logo

Live Shigella flexneri 2a and Shigella sonnei I vaccine candidate strains with two attenuating markers. I. Construction of vaccine candidate strains with retained invasiveness but reduced intracellular multiplication. 1990

K Linde, and V Dentchev, and V Bondarenko, and S Marinova, and B Randhagen, and M Bratoyeva, and Y Tsvetanov, and Y Romanova
Institute of Medical Microbiology and Epidemiology, Karl Marx University, Leipzig, GDR.

Live Shigella flexneri 2a and Shigella sonnei Phase I vaccine candidate strains with two virulence-reducing markers were constructed through stepwise incorporation of weakly attenuating purine auxotrophy with subsequent rifampicin-resistance (RNA polymerase) mutation to yield optimal attenuation. These vaccine candidate strains showed an unaltered plasmid profile; did not cause keratoconjunctivitis in the Sereny test, while being excreted for a short but still marked period and providing partial protection from wild-strain infection; exhibited for guinea-pig conjunctival epithelia, HeLa cells and rat enterocytes a maintained invasiveness with reduced intracellular multiplication with little, if any, reversible cell damage; and produced, just as their ultrasonic lysates, no exudative reaction in the rabbit gut loop test.

UI MeSH Term Description Entries
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D003228 Conjunctiva The mucous membrane that covers the posterior surface of the eyelids and the anterior pericorneal surface of the eyeball. Bulbar Conjunctiva,Palpebral Conjunctiva,Plica Semilunaris of Conjunctiva,Plicae Semilunares of Conjunctiva,Tunica Conjunctiva,Conjunctiva, Bulbar,Conjunctiva, Palpebral,Conjunctivas
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001428 Bacterial Vaccines Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. Bacterial Vaccine,Bacterin,Vaccine, Bacterial,Vaccines, Bacterial
D012763 Shigella flexneri A bacterium which is one of the etiologic agents of bacillary dysentery (DYSENTERY, BACILLARY) and sometimes of infantile gastroenteritis.

Related Publications

K Linde, and V Dentchev, and V Bondarenko, and S Marinova, and B Randhagen, and M Bratoyeva, and Y Tsvetanov, and Y Romanova
Construction of a stable and non-resistant bivalent vaccine candidate strain against Shigella flexneri 2a and Shigella sonnei.
January 1996, Chinese journal of biotechnology,
K Linde, and V Dentchev, and V Bondarenko, and S Marinova, and B Randhagen, and M Bratoyeva, and Y Tsvetanov, and Y Romanova
Potential Shigella flexneri 2a and Shigella sonnei I live vaccinal strains. Characterization of immunogenicity in animal models.
January 1990, Acta microbiologica Hungarica,
K Linde, and V Dentchev, and V Bondarenko, and S Marinova, and B Randhagen, and M Bratoyeva, and Y Tsvetanov, and Y Romanova
[Live shigella flexneri 2a and shigella sonnei vaccines (author's transl)].
January 1974, Acta microbiologica Academiae Scientiarum Hungaricae,
K Linde, and V Dentchev, and V Bondarenko, and S Marinova, and B Randhagen, and M Bratoyeva, and Y Tsvetanov, and Y Romanova
Construction of aromatic dependent Shigella flexneri 2a live vaccine candidate strains: deletion mutations in the aroA and the aroD genes.
January 1991, Vaccine,
K Linde, and V Dentchev, and V Bondarenko, and S Marinova, and B Randhagen, and M Bratoyeva, and Y Tsvetanov, and Y Romanova
Construction and evaluation of live attenuated vaccine strains of Shigella flexneri and Shigella dysenteriae 1.
January 1990, Research in microbiology,
K Linde, and V Dentchev, and V Bondarenko, and S Marinova, and B Randhagen, and M Bratoyeva, and Y Tsvetanov, and Y Romanova
Construction and evaluation of a virG thyA double mutant of Shigella flexneri 2a as a candidate live-attenuated oral vaccine.
January 1995, Vaccine,
K Linde, and V Dentchev, and V Bondarenko, and S Marinova, and B Randhagen, and M Bratoyeva, and Y Tsvetanov, and Y Romanova
Interferon treatment reduced adherence, invasiveness and intracellular multiplication of Shigella flexneri in coxsackie B1 virus-infected cells.
January 1992, Journal of biological regulators and homeostatic agents,
K Linde, and V Dentchev, and V Bondarenko, and S Marinova, and B Randhagen, and M Bratoyeva, and Y Tsvetanov, and Y Romanova
[Construction and characterization of a live attenuated Shigella flexneri 2a vaccine strain, sf301 Delta virG and dsbA33G].
October 2005, Wei sheng wu xue bao = Acta microbiologica Sinica,
K Linde, and V Dentchev, and V Bondarenko, and S Marinova, and B Randhagen, and M Bratoyeva, and Y Tsvetanov, and Y Romanova
Plasmid-mediated intracellular multiplication of Shigella flexneri.
January 1986, Annales de l'Institut Pasteur. Microbiologie,
K Linde, and V Dentchev, and V Bondarenko, and S Marinova, and B Randhagen, and M Bratoyeva, and Y Tsvetanov, and Y Romanova
Colicinogeny and colicin sensitivity of Shigella flexneri and Shigella sonnei strains.
January 1968, Archivum immunologiae et therapiae experimentalis,
Copied contents to your clipboard!